Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Articles published by Achieve Life Sciences

Achieve Life Sciences Announces Refresh to Board of Directors
From Achieve Life Sciences
Via GlobeNewswire
Tickers ACHV
Achieve Life Sciences Announces Last Subject Last Visit Completed in Phase 3 ORCA-3 Trial of Cytisinicline for Smoking Cessation
From Achieve Life Sciences
Via GlobeNewswire
Tickers ACHV
Achieve Life Sciences Announces Presentation of the Phase 3 ORCA-2 Trial of Cytisinicline at Society for Research on Nicotine and Tobacco (SRNT) Annual Meeting
From Achieve Life Sciences
Via GlobeNewswire
Tickers ACHV
Achieve Life Sciences to Announce Fourth Quarter and Year-End 2022 Financial Results and Host Conference Call and Webcast on March 16, 2023
From Achieve Life Sciences
Via GlobeNewswire
Tickers ACHV
Achieve Life Sciences Announces Last Subject Dosed in Phase 2 ORCA-V1 Trial of Cytisinicline for e-Cigarette Cessation
From Achieve Life Sciences
Via GlobeNewswire
Tickers ACHV
Achieve Life Sciences Announces Granting of New Hire Inducement Award
From Achieve Life Sciences
Via GlobeNewswire
Tickers ACHV
Achieve Life Sciences Announces Granting of New Hire Inducement Award
From Achieve Life Sciences
Via GlobeNewswire
Tickers ACHV
Achieve Life Sciences Announces Last Subject Last Visit Completed in Phase 2 ORCA-V1 Trial of Cytisinicline for e-Cigarette Cessation
From Achieve Life Sciences
Via GlobeNewswire
Tickers ACHV
Achieve Life Sciences to Participate at the 2023 SVB Securities Global Biopharma Conference
From Achieve Life Sciences
Via GlobeNewswire
Tickers ACHV
Achieve Life Sciences Announces Last Subject Dosed in Phase 3 ORCA-3 Trial of Cytisinicline for Smoking Cessation
From Achieve Life Sciences
Via GlobeNewswire
Tickers ACHV
Achieve Life Sciences Announces Patent Granted by USPTO for New Cytisinicline Formulation
From Achieve Life Sciences
Via GlobeNewswire
Tickers ACHV
Achieve Life Sciences Announces Private Placement of $18.9 Million
From Achieve Life Sciences
Via GlobeNewswire
Tickers ACHV
Achieve Announces Early Completion of Target Enrollment in Cytisinicline e-Cigarette Cessation Trial
From Achieve Life Sciences
Via GlobeNewswire
Tickers ACHV
Achieve Life Sciences to Announce Third Quarter Financial Results and Host Conference Call and Webcast on November 14, 2022
From Achieve Life Sciences
Via GlobeNewswire
Tickers ACHV
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.